Literature DB >> 16125836

The structure of human apolipoprotein E2, E3 and E4 in solution. 2. Multidomain organization correlates with the stability of apoE structure.

Vanessa Clément-Collin1, Anne Barbier, Alexander D Dergunov, Athanase Visvikis, Gérard Siest, Michel Desmadril, Masa Takahashi, Lawrence P Aggerbeck.   

Abstract

The stabilities toward thermal and chemical denaturation of three recombinant isoforms of human apolipoprotein E (r-apoE2, r-apoE3 and r-apoE4), human plasma apoE3, the recombinant amino-terminal (NT) and the carboxyl-terminal (CT) domains of plasma apoE3 at pH 7 were studied using near and far ultraviolet circular dichroism (UV CD), fluorescence and size-exclusion chromatography. By far UV CD, thermal unfolding was irreversible for the intact apoE isoforms and consisted of a single transition. The r-apoE3 was found to be less stable as compared to the plasma protein and the stability of recombinant isoforms was r-apoE4<r-apoE3<r-apoE2. The thermal denaturation of the isolated NT- and CT-domains of apoE3 was largely reversible and included two transitions. The NT-domain was more resistant to heating than the CT-domain, both of which were more resistant than the intact protein. By near UV CD, the thermal unfolding was biphasic. When compared, thermal unfolding of the secondary and tertiary structures appeared to occur concurrently in r-apoE2 whereas heating affected the tertiary structure, initially, in r-apoE3 and r-apoE4. Denaturation with guanidine hydrochloride did not follow a two-state transition. A three-state treatment of the denaturation curves revealed the order of stability as r-apoE4<r-apoE3<r-apoE2 for the whole proteins as well as that for the NT-domains, as established by fluorescence and far UV CD spectroscopy, whereas the CT-domains had roughly similar stabilities. There are isoform-specific differences in the stability and in the state of association and the unfolding of both the NT- and CT-domains may be more complex than a two-state transition.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16125836     DOI: 10.1016/j.bpc.2005.07.009

Source DB:  PubMed          Journal:  Biophys Chem        ISSN: 0301-4622            Impact factor:   2.352


  14 in total

1.  Apolipoprotein-E forms dimers in human frontal cortex and hippocampus.

Authors:  David A Elliott; Glenda M Halliday; Brett Garner
Journal:  BMC Neurosci       Date:  2010-02-20       Impact factor: 3.288

2.  Semisynthesis and segmental isotope labeling of the apoE3 N-terminal domain using expressed protein ligation.

Authors:  Paul S Hauser; Vincent Raussens; Taichi Yamamoto; Gezman E Abdullahi; Paul M M Weers; Brian D Sykes; Robert O Ryan
Journal:  J Lipid Res       Date:  2008-12-19       Impact factor: 5.922

3.  Capillary isotachophoresis study of lipoprotein network sensitive to apolipoprotein E phenotype. 1. ApoE distribution between lipoproteins.

Authors:  Alexander D Dergunov; Anne Ponthieux; Maxim V Mel'kin; Daniel Lambert; Sophie Visvikis-Siest; Gerard Siest
Journal:  Mol Cell Biochem       Date:  2009-01-13       Impact factor: 3.396

4.  Thermodynamic and structural destabilization of apoE3 by hereditary mutations associated with the development of lipoprotein glomerulopathy.

Authors:  Dimitra Georgiadou; Kostas Stamatakis; Eleni K Efthimiadou; George Kordas; Donald Gantz; Angeliki Chroni; Efstratios Stratikos
Journal:  J Lipid Res       Date:  2012-10-30       Impact factor: 5.922

5.  HtrA1 Proteolysis of ApoE In Vitro Is Allele Selective.

Authors:  Qian Chu; Jolene K Diedrich; Joan M Vaughan; Cynthia J Donaldson; Michael F Nunn; Kuo-Fen Lee; Alan Saghatelian
Journal:  J Am Chem Soc       Date:  2016-07-19       Impact factor: 15.419

6.  Thermodynamic destabilization and aggregation propensity as the mechanism behind the association of apoE3 mutants and lipoprotein glomerulopathy.

Authors:  Maria Katsarou; Efstratios Stratikos; Angeliki Chroni
Journal:  J Lipid Res       Date:  2018-10-11       Impact factor: 5.922

7.  Molecular basis for increased risk for late-onset Alzheimer disease due to the naturally occurring L28P mutation in apolipoprotein E4.

Authors:  Letta Argyri; Ioannis Dafnis; Theodossis A Theodossiou; Donald Gantz; Efstratios Stratikos; Angeliki Chroni
Journal:  J Biol Chem       Date:  2014-03-18       Impact factor: 5.157

8.  Function and comorbidities of apolipoprotein e in Alzheimer's disease.

Authors:  Valérie Leduc; Dorothée Domenger; Louis De Beaumont; Daphnée Lalonde; Stéphanie Bélanger-Jasmin; Judes Poirier
Journal:  Int J Alzheimers Dis       Date:  2011-04-05

9.  Structural and functional characterization of human apolipoprotein E 72-166 peptides in both aqueous and lipid environments.

Authors:  Yi-Hui Hsieh; Chi-Yuan Chou
Journal:  J Biomed Sci       Date:  2011-01-10       Impact factor: 8.410

10.  Biophysical analysis of apolipoprotein E3 variants linked with development of type III hyperlipoproteinemia.

Authors:  Dimitra Georgiadou; Angeliki Chroni; Alexander Vezeridis; Vassilis I Zannis; Efstratios Stratikos
Journal:  PLoS One       Date:  2011-11-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.